DK0956281T3 - Hidtil ukendte modifikationer af 2-amino-4-(4-fluorbenzylamino)-1-ethoxycarbonylaminobenzen, såvel som fremgangsmåder til deres fremstilling - Google Patents

Hidtil ukendte modifikationer af 2-amino-4-(4-fluorbenzylamino)-1-ethoxycarbonylaminobenzen, såvel som fremgangsmåder til deres fremstilling

Info

Publication number
DK0956281T3
DK0956281T3 DK98904048T DK98904048T DK0956281T3 DK 0956281 T3 DK0956281 T3 DK 0956281T3 DK 98904048 T DK98904048 T DK 98904048T DK 98904048 T DK98904048 T DK 98904048T DK 0956281 T3 DK0956281 T3 DK 0956281T3
Authority
DK
Denmark
Prior art keywords
ethoxycarbonylaminobenzene
fluorobenzylamino
amino
preparation
methods
Prior art date
Application number
DK98904048T
Other languages
Danish (da)
English (en)
Inventor
Peter Meisel
Karl-Friedrich Landgraf
Juergen Schaefer
Alfred Olbrich
Bernhard Kutscher
Matthias Rischer
Wilfried Thiel
Original Assignee
Viatris Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Viatris Gmbh filed Critical Viatris Gmbh
Application granted granted Critical
Publication of DK0956281T3 publication Critical patent/DK0956281T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/26—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a six-membered aromatic ring
    • C07C271/28—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a six-membered aromatic ring to a carbon atom of a non-condensed six-membered aromatic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
DK98904048T 1997-01-20 1998-01-09 Hidtil ukendte modifikationer af 2-amino-4-(4-fluorbenzylamino)-1-ethoxycarbonylaminobenzen, såvel som fremgangsmåder til deres fremstilling DK0956281T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19701694A DE19701694A1 (de) 1997-01-20 1997-01-20 Neue Modifikationen des 2-Amino-4-(4-fluorbenzylamino)-l-ethoxycarbonyl-aminobenzen sowie Verfahren zu ihrer Herstellung
PCT/EP1998/000086 WO1998031663A1 (fr) 1997-01-20 1998-01-09 Nouvelles modifications du 2-amino-4-(4-fluorobenzylamino)-1-ethoxycarbonyle-aminobenzene et procedes permettant de preparer ledit compose

Publications (1)

Publication Number Publication Date
DK0956281T3 true DK0956281T3 (da) 2002-11-04

Family

ID=7817756

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98904048T DK0956281T3 (da) 1997-01-20 1998-01-09 Hidtil ukendte modifikationer af 2-amino-4-(4-fluorbenzylamino)-1-ethoxycarbonylaminobenzen, såvel som fremgangsmåder til deres fremstilling

Country Status (31)

Country Link
US (2) US5914425A (fr)
EP (1) EP0956281B1 (fr)
JP (1) JP4138886B2 (fr)
CN (1) CN1125812C (fr)
AR (1) AR015349A1 (fr)
AT (1) ATE222235T1 (fr)
AU (1) AU730776B2 (fr)
BG (1) BG63893B1 (fr)
BR (1) BR9806784A (fr)
CA (3) CA2278201C (fr)
CZ (1) CZ301778B6 (fr)
DE (2) DE19701694A1 (fr)
DK (1) DK0956281T3 (fr)
EG (1) EG21239A (fr)
ES (1) ES2178152T3 (fr)
HK (1) HK1024230A1 (fr)
HU (1) HU227625B1 (fr)
ID (1) ID22645A (fr)
IL (1) IL130384A (fr)
IS (1) IS2115B (fr)
NO (2) NO311642B1 (fr)
NZ (1) NZ336205A (fr)
PL (1) PL195956B1 (fr)
PT (1) PT956281E (fr)
RU (1) RU2186765C2 (fr)
SK (1) SK285303B6 (fr)
TR (1) TR199901674T2 (fr)
TW (1) TW531527B (fr)
UA (1) UA63937C2 (fr)
WO (1) WO1998031663A1 (fr)
ZA (1) ZA98319B (fr)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI287984B (en) 2000-10-17 2007-10-11 Wyeth Corp Pharmaceutical composition for modulating bladder function
US6589986B2 (en) 2000-12-20 2003-07-08 Wyeth Methods of treating anxiety disorders
AR033095A1 (es) * 2001-04-04 2003-12-03 Wyeth Corp Metodos para el tratamiento de motilidad gastrica hiperactiva
US20050089559A1 (en) * 2003-10-23 2005-04-28 Istvan Szelenyi Combinations of potassium channel openers and sodium channel inhibitors or sodium channel-influencing active compounds for treating pains
US7960436B2 (en) * 2006-06-05 2011-06-14 Valeant Pharmaceuticals International Substituted arylamino-1,2,3,4-tetrahydro naphthalenes and-2,3-dihydro-1H-indenes as potassium channel modulators
US20080045534A1 (en) * 2006-08-18 2008-02-21 Valeant Pharmaceuticals North America Derivatives of 1,3-diamino benzene as potassium channel modulators
US8993593B2 (en) * 2006-08-23 2015-03-31 Valeant Pharmaceuticals International N-(4-(6-fluoro-3,4-dihydroisoquinolin-2(1H)-yl)-2,6-dimethylphenyl)-3,3-dimethylbutanamide as potassium channel modulators
ES2420960T3 (es) * 2006-08-23 2013-08-28 Valeant Pharmaceuticals International Derivados de 4-(N-azacicloalquil)anilidas como moduladores de los canales de potasio
US8722929B2 (en) * 2006-10-10 2014-05-13 Valeant Pharmaceuticals International N-[2-amino-4-(phenylmethoxy)phenyl] amides and related compounds as potassium channel modulators
ES2375417T3 (es) * 2006-11-28 2012-02-29 Valeant Pharmaceuticals International Análogos 1,4-diamino bicíclicos de retigabina como moduladores de los canales de potasio.
US8367684B2 (en) * 2007-06-13 2013-02-05 Valeant Pharmaceuticals International Derivatives of 4-(N-azacycloalkyl) anilides as potassium channel modulators
US8563566B2 (en) 2007-08-01 2013-10-22 Valeant Pharmaceuticals International Naphthyridine derivatives as potassium channel modulators
US7786146B2 (en) * 2007-08-13 2010-08-31 Valeant Pharmaceuticals International Derivatives of 5-amino-4,6-disubstituted indole and 5-amino-4,6-disubstituted indoline as potassium channel modulators
CA2731008A1 (fr) * 2008-07-18 2010-01-21 Valeant Pharmaceuticals International Formulation a liberation modifiee et procedes d'utilisation
US20100323015A1 (en) * 2008-07-18 2010-12-23 Biljana Nadjsombati Modified release formulation and methods of use
US20100323016A1 (en) * 2008-07-18 2010-12-23 Biljana Nadjsombati Modified release formulation and methods of use
DE102009013612A1 (de) 2009-03-17 2010-09-23 Ratiopharm Gmbh Retigabin-Tabletten, bevorzugt mit modifizierter Freisetzung
DE102009013611A1 (de) 2009-03-17 2010-09-23 Ratiopharm Gmbh Festes Retigabin in nicht-kristalliner Form
DE102009013613A1 (de) 2009-03-17 2010-09-23 Ratiopharm Gmbh Trockenverarbeitung von Retigabin
WO2011039369A2 (fr) 2009-10-02 2011-04-07 Medichem S.A. Formes amorphes d'un dérivé de 2-amino-4-(4-fluorobenzylamino)phénylcarbamate
EA201290659A1 (ru) 2010-01-20 2013-05-30 Глэксо Груп Лимитед Новая композиция ретигабина
US20130131164A1 (en) * 2010-02-19 2013-05-23 Medichem, S.A. Stabilized phenylcarbamate derivative in solid state
CN202095728U (zh) * 2010-10-29 2012-01-04 假日集团控股有限公司 行李箱把手
CN102464233A (zh) * 2010-11-18 2012-05-23 江苏邦威机械制造有限公司 一种卧式差速缠丝机用应力发生装置
US9102593B2 (en) 2011-01-18 2015-08-11 Glaxo Group Limited Process for the preparation of retigabine
CN102241608A (zh) * 2011-05-12 2011-11-16 天津市汉康医药生物技术有限公司 瑞替加滨化合物及其组合物
WO2013008250A2 (fr) * 2011-07-01 2013-01-17 Dr.Reddys Laboratories Limited. Forme cristalline de la rétigabine et procédés de mélange de variétés cristallines de la rétigabine
WO2013011518A1 (fr) 2011-07-21 2013-01-24 Arch Pharmalabs Limited Procédé de préparation de rétigabine de formule i et de ses sels pharmaceutiquement acceptables
CN102531966B (zh) * 2011-12-23 2013-07-24 山东创新药物研发有限公司 瑞替加滨的晶型d及其制备方法
WO2013114379A1 (fr) * 2012-01-30 2013-08-08 Symed Labs Limited Nouveaux polymorphes d'ester éthylique de l'acide carbamique n-[2-amino-4-(4-fluorobenzylamino)-phényl] et procédés associés
CN103373941B (zh) * 2012-04-11 2016-08-17 浙江九洲药物科技有限公司 瑞替加滨及其中间体的制备方法
WO2013179298A2 (fr) * 2012-04-23 2013-12-05 Cadila Healthcare Limited Procédé pour la préparation d'un dérivé de phénylcarbamate et de formes polymorphes de celui-ci
WO2014023270A1 (fr) 2012-08-09 2014-02-13 Zentiva, K.S. Sels ou co-cristaux de n-[2-amino-4-[(4-fluorophényl)méthylamino]-phényl]carbamate d'éthyle
CN102964273B (zh) * 2012-12-06 2014-04-02 北京英科博雅科技有限公司 瑞替加滨的新晶型f及其制备方法
USD773819S1 (en) 2015-05-27 2016-12-13 Travelpro Products, Inc. Handle for luggage

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4200259A1 (de) * 1992-01-08 1993-07-15 Asta Medica Ag Neue 1,2,4-triaminobenzol-derivate und verfahren zu deren herstellung

Also Published As

Publication number Publication date
UA63937C2 (uk) 2004-02-16
IS2115B (is) 2006-06-15
DE19701694A1 (de) 1998-07-23
BG103657A (en) 2000-02-29
CA2634811C (fr) 2012-11-20
NO311642B1 (no) 2001-12-27
PL335647A1 (en) 2000-05-08
ZA98319B (en) 1998-05-07
SK95699A3 (en) 2000-03-13
IL130384A (en) 2003-02-12
PL195956B1 (pl) 2007-11-30
CA2634811A1 (fr) 1998-07-23
CN1125812C (zh) 2003-10-29
WO1998031663A1 (fr) 1998-07-23
HUP0000944A3 (en) 2000-10-30
CA2278201C (fr) 2009-06-16
NZ336205A (en) 2000-01-28
ATE222235T1 (de) 2002-08-15
BR9806784A (pt) 2000-05-02
AR015349A1 (es) 2001-05-02
AU6208198A (en) 1998-08-07
JP4138886B2 (ja) 2008-08-27
HU227625B1 (en) 2011-09-28
NO2011017I2 (no) 2013-04-02
US6538151B1 (en) 2003-03-25
CZ301778B6 (cs) 2010-06-23
NO2011017I1 (no) 2011-09-26
EP0956281B1 (fr) 2002-08-14
US5914425A (en) 1999-06-22
ES2178152T3 (es) 2002-12-16
RU2186765C2 (ru) 2002-08-10
BG63893B1 (bg) 2003-05-30
TR199901674T2 (fr) 1999-10-21
CA2632585A1 (fr) 1998-07-23
IS5098A (is) 1999-06-29
EP0956281A1 (fr) 1999-11-17
EG21239A (en) 2001-03-31
HK1024230A1 (en) 2000-10-05
SK285303B6 (sk) 2006-10-05
HUP0000944A2 (hu) 2000-09-28
CZ250899A3 (cs) 1999-11-17
ID22645A (id) 1999-12-02
JP2001508077A (ja) 2001-06-19
CA2632585C (fr) 2010-08-24
IL130384A0 (en) 2000-06-01
PT956281E (pt) 2002-12-31
TW531527B (en) 2003-05-11
CA2278201A1 (fr) 1998-07-23
AU730776B2 (en) 2001-03-15
NO993452L (no) 1999-07-13
NO993452D0 (no) 1999-07-13
DE59805186D1 (de) 2002-09-19
CN1243506A (zh) 2000-02-02

Similar Documents

Publication Publication Date Title
DK0956281T3 (da) Hidtil ukendte modifikationer af 2-amino-4-(4-fluorbenzylamino)-1-ethoxycarbonylaminobenzen, såvel som fremgangsmåder til deres fremstilling
DK1176195T3 (da) Fremgangsmåde til at kontrollere aktiviteten af immunologisk funktionelt molekyle
DK1038008T3 (da) Fremgangsmåde til fremstilling af EGIII-lignende enzymer
DK1296935T3 (da) Fremgangsmåde til fremstilling af substituerede octanoylamider
DK1032566T3 (da) Fremgangsmåde til fremstilling af citalopram
DK1173431T3 (da) Fremgangsmåde til fremstilling af citalopram
DK1105382T3 (da) Fremgangsmåde til fremstilling af citalopram
DK1008577T4 (da) Fremgangsmåde til fremstilling af methanol
DK0937055T3 (da) Fremgangsmåde til fremstilling af d,I-alfa-tocopherol
DK1309581T3 (da) Fremgangsmåde til fremstilling af citalopram
DK0912537T3 (da) Fremgangsmåde til fremstilling af phenylheterocykliske forbindelser, der er anvendelige som cox-2-inhibitorer
DK1142990T3 (da) Fremgangsmåde til fremstilling af transglutaminase
DK0996642T3 (da) Fremgangsmåde til fremstilling af heparin
DK1170591T3 (da) Fremgangsmåde til identifikation af kombinationer af forbindelser som terapeutiske midler
DK0966445T3 (da) Fremgangsmåder til fremstilling af mellemprodukter til pesticider
DK1326836T3 (da) Fremgangsmåde til fremstilling af 3-amino-2-chlor-4-methylpyridin
DK0970939T3 (da) Fremgangsmåde til fremstilling af methanol
DK0864564T3 (da) Særlig fremgangsmåde til fremstillingen af alfa-bromlactamderivater
DK0927766T3 (da) Enzymatisk fremgangsmåde til fremstilling af (S)-cyanhydriner
DK0973769T3 (da) Fremgangsmåde til fremstilling af eprosartan
DK0951561T3 (da) Enzymatiske fremgangsmåder til fremstilling af (S)-cyanhydriner
DK0970073T3 (da) Fremgangsmåde til fremstilling af eprosartan
DK1298124T3 (da) Fremgangsmåde til fremstilling af citalopram
DK1062358T3 (da) Ny fremgangsmåde til fremstilling af fexofenadin
DK0915076T3 (da) Fremgangsmåde til fremstilling af trans-(R,R)-actinol